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Members of the Conserved DedA Family Are Likely Membrane
Transporters and Are Required for Drug Resistance in Escherichia coli
Sujeet Kumar, William T. Doerrler
‹Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA
Bacterial resistance to antibiotics and biocides is an increasing public health problem. Genes encoding integral membrane pro-
teins belonging to the DedA family are present in most bacterial genomes, including Escherichia coli. An E. coli strain lacking
partially redundant DedA family genes yqjA and yghB (strain BC202) displays temperature sensitivity and cell division defects.
These phenotypes can be corrected by overexpression of mdfA, an Na-K/H antiporter of the major facilitator superfamily.
We show that BC202 is hypersensitive to several biocides and cationic compounds that are known substrates of several multi-
drug resistance transporters, including MdfA, EmrE, and AcrB. The introduction of deletions of genes encoding these drug
transporters into BC202 results in additional sensitivity. Expression of wild-type yghB or yqjA can restore drug resistance, but
this is eliminated upon mutation of two membrane-embedded acidic amino acids (E39 or D51 in either protein). This depen-
dence upon membrane-embedded acidic amino acids is a hallmark of proton-dependent antiporters. Overexpression of mdfA in
BC202 or artificially restoring proton motive force (PMF) restores wild-type resistance to substrates of MdfA as well as other
drug resistance transporters such as EmrE and AcrAB. These results suggest that YqjA and YghB may be membrane transporters
required for PMF-dependent drug efflux in E. coli.
Bacterial resistance to biocides and antibiotics is an increasingproblem. Resistance is often conferred by expression of efflux
pumps that can accommodate numerous unrelated drugs (1, 2).
Efflux pumps belonging to the major facilitator superfamily
(MFS), the small multidrug resistance (SMR) family, and ABC
transporter families are found widespread throughout evolution.
While the functions of these protein families have been studied in
detail, genome sequencing projects have revealed the existence of
many families of membrane proteins whose functions are not well
understood (3).
DedA is a large superfamily of membrane proteins that are
found within all three domains of life and are present in nearly all
sequenced bacterial genomes (4). They are sometimes annotated
“SNARE-associated family” based on homology to yeast Tvp38
(5). Protein databases do not classify members of the DedA family
as membrane transporters. They bear no amino acid similarity to
the MFS, SMR family, ABC transporters, ion channels, or other
types of transporters. They bear limited similarity to the LeuT
family of transporters when analyzed using a novel type of evolu-
tionary analysis called AlignMe (6). The Escherichia coli genome
encodes eight members of the DedA family displaying 25 to 60%
amino acid identity (annotated dedA, yqjA, yghB, yabI, yohD,
yqaA, ydjX, and ydjZ) (7). YqjA and YghB are DedA family pro-
teins of 220 and 219 amino acids, respectively, with 61% amino
acid identity and partially redundant functions. Simultaneous in-
frame deletion of these two DedA family genes in strain BC202
(W3110 yghB, yqjA) results in numerous phenotypes, includ-
ing temperature sensitivity (8), cell division defects due to ineffi-
cient export of periplasmic amidases by the twin-arginine path-
way (9), and activation of envelope stress response pathways and
compromised membrane proton motive force (PMF) (10). Via-
bility at elevated temperatures and normal cell division can be
restored to BC202 by growth at pH 6.0 (10) or overexpression of a
subset of DedA family genes (8, 11) or mdfA (10), encoding an
Na-K/H antiporter belonging to the MFS (12). These results
suggest roles for YqjA/YghB in maintenance of the pH gradient
(pH) component of the PMF, composed of both the electrical
potential () and the pH (12). The yqjA mutant is sensitive
to alkaline pH (13), and yqjA expression is repressed at low pH
(14), suggesting that one function of YqjA may be to promote
alkaline tolerance. Similar functions have been shown for E. coli
MdfA and Bacillus subtilis Tet(L) (1, 15, 16). A role for YqjA/YghB
in PMF maintenance is also supported by our own direct measure-
ments of  in BC202 using the JC-1 dye-based assay (10).
In addition to functioning as an ion transporter, MdfA exports
numerous cationic and zwitterionic lipophilic compounds (17).
Overexpression of MdfA increases resistance of E. coli to a wide
variety of structurally diverse drugs and biocides (18), and mdfA
mutants are sensitive to exposure to such compounds (19). Given
the ability of MdfA to correct the observed phenotypes of BC202,
we measured the growth of BC202 and its parent strain W3110 in
the presence of biocidal drugs and dyes belonging to different
classes. We found that BC202 is hypersensitive to a number of
structurally diverse compounds. Resistance can be restored to
BC202 by expression of DedA family gene yghB or yqjA. Mutation
of membrane-embedded acidic amino acids compromised the
ability of YghB and YqjA to restore resistance to BC202, suggesting
that these E. coli membrane proteins are possibly a new class of
membrane proton-dependent transporters.
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Materials. All chemicals were reagent grade and purchased from Sigma-
Aldrich or VWR. Restriction enzymes, DNA polymerases, and T4 DNA
ligase were purchased from New England BioLabs. The following com-
pounds were used for the susceptibility testing, and their classes/modes of
action and sources are given in parentheses: chloramphenicol (Sigma-
Aldrich), erythromycin (macrolide; Sigma-Aldrich), ciprofloxacin (fluo-
roquinolone; Sigma-Aldrich), norfloxacin (fluoroquinolone; Sigma-
Aldrich), nalidixic acid (quinolone precursor; Sigma-Aldrich), sodium
dodecyl sulfate (detergent; Bio-Rad), acriflavine hydrochloride (interca-
lator; Acros Organics), ethidium bromide (EthBr) (intercalator; Am-
resco), cetyltrimethyl ammonium bromide (CTAB) (quaternary ammo-
nium compound; Amresco), benzalkonium chloride (quaternary amino
compound; Alfa Aesar), methyl viologen (redox cycling drug; Acros Or-
ganics), oxacillin (penicillin; Sigma-Aldrich), cloxacillin (penicillin;
Sigma-Aldrich), and piperacillin (penicillin; TCI America).
Bacterial growth conditions. Bacterial cultures were grown in Luria-
Bertani broth (LB) (1% tryptone, 0.5% yeast extract, and 1% NaCl) unless
otherwise stated. LB medium of pH 6.0 was buffered with 100 mM 2-(N-
morpholino)-ethanesulfonic acid (MES) (10). Solid media were obtained
by addition of 1.5% agar (wt/vol). When required, the medium was sup-
plemented with ampicillin (Amp) at 100 g/ml, kanamycin (Kan) at 30
g/ml, tetracycline (Tet) at 12.5 g/ml, chloramphenicol (Cam) at 30
g/ml, arabinose (0.002% or 0.1%, wt/vol), or isopropyl-1-thio--D-ga-
lactopyranoside (IPTG) (0.5 mM). All cultures were grown at 30°C unless
otherwise indicated.
Strain construction. The multiple-deletion mutants were generated
in E. coli W3110, and correct configuration was verified through PCR with
primers flanking the appropriate gene. In order to eliminate the kanamy-
cin resistance (Kanr) gene from BC202, plasmid pCP20 expressing FLP
recombinase was used as described previously (20). Since this protocol
requires overnight incubation at 42°C to cure pCP20 (nonpermissive for
BC202), the yghB::Kanr strain was first made markerless (W3110 back-
ground). yqjA::Tetr (8) was then introduced by P1 transduction. Addi-
tional mutations (i.e., emrE::Kanr, mdfA::Kanr, or acrB::Kanr) were
introduced by P1 transduction with P1vir lysate prepared from the indi-
cated E. coli strains (see Table S1 in the supplemental material) obtained
from the Keio collection (21). P1 transductions were carried out as de-
scribed previously (22). All strains and genotypes are listed in Table S1 in
the supplemental material.
Microscopy. Overnight cultures of E. coli strains were diluted 1:100 in
fresh LB medium with suitable antibiotics and additives, and grown to an
optical density at 600 nm (OD600) of  0.6 at 30°C in a shaking incubator.
Cells were resuspended to a final OD600 of 1.0 in LB, and 10 l of cells was
applied to a 1% agarose coated glass slide for imaging. A Leica DM-RXA2
deconvolution microscope was used for all of the differential interference
contrast (DIC) micrographs. Observations were made with a 100, 1.30-
numerical-aperture oil immersion objective lens. The images were cap-
tured through a DIC filter by a cooled Cooke SensiCamQE 12-bit, 1,3-
megapixel charge-coupled device digital camera and recorded using
Slidebook software (Intelligent Imaging Innovation, Denver, CO).
Susceptibility to toxic compounds. For testing the susceptibility on
solid medium, overnight cultures of E. coli strains were freshly diluted
1:100 in LB medium with appropriate antibiotics and additives and grown
to an OD600 of 0.6 at 30°C in a shaking incubator. Five microliters of
serially log10-diluted cells was spotted on LB agar plates containing vari-
ous concentrations of corresponding biocides. Growth was analyzed after
incubation for 20 to 24 h at 30°C. All experiments were repeated at least
three times.
MIC determination. The MICs of biocides were carried out using a
2-fold dilution technique either in 1.5- by 15-cm glass tubes or in 96-well
microtiter plates in liquid medium (23). Overnight cultures were freshly
diluted 1:100 into LB medium with suitable antibiotics and additives.
Exponentially growing cultures at an OD600 of 1.0 were inoculated at a
density of 105 cells per ml into LB medium supplemented with a series of
2-fold dilutions of indicated biocide. Cell growth was determined visually
after incubation at 30°C for 24 h. All experiments were repeated at least
three times.
Site-directed mutagenesis. Site-specific mutants were created by us-
ing a previously published protocol (24). The primers carrying the site-
specific mutations (see Table S2 in the supplemental material) were used
in a PCR to amplify a vector containing the specified wild-type gene. The
PCR product was then digested with DpnI and used to transform compe-
tent XL1-Blue cells. Colonies obtained after transformation were screened
by colony PCR using gene-specific primers. The mutations were con-
firmed by DNA sequencing conducted at the LSU College of Science
Genomics Facility.
Membrane preparation and Western blotting. Cell membranes was
prepared from exponential-phase cultures of BC202 containing appropri-
ate plasmid DNA grown under inducing condition (0.1% arabinose or 0.5
mM IPTG) using a previously published protocol (25). Equal amounts of
protein were resolved by 12% SDS-PAGE and transfer to polyvinylidene
difluoride (PVDF). Western blotting was done using penta-His (Qiagen)
or green fluorescent protein (GFP) (JL-8; Clontech) primary antibody at
a 1:5,000 dilution and goat anti-mouse horseradish peroxidase (HRP)-
conjugated secondary antibody (Pierce) at 1:5,000. Detection was carried
out using the ImmunStar HRP kit (Bio-Rad).
RESULTS
A DedA family mutant is highly sensitive to a number of bio-
cides. Ethidium bromide (EthBr) efflux is a hallmark of several
bacterial organic cation transporters, including MdfA (16, 17),
EmrE (26), and QacA (27). We tested for sensitivity to EthBr using
a standard growth assay and found that BC202 is significantly
more sensitive than the parent strain W3110 to this cationic dye
(Fig. 1A). We also observed increased sensitivity of BC202 to bio-
cides known to be exported by other drug efflux proteins (19, 28,
29), including methyl viologen (resistance conferred by EmrE),
benzalkonium chloride (mainly MdfA), cetyltrimethyl ammo-
nium bromide (mainly AcrAB), nalidixic acid (AcrAB), acrifla-
vine (EmrE and AcrAB), and -lactam antibiotics (AcrAB) on
solid (Fig. 1B and C; see Fig. 3B) and/or liquid (Table 1) media.
We have tested BC202 for sensitivity to many antibiotics and other
compounds (8) and have found that BC202 is not generally hy-
persensitive to all biocides. For example, BC202 is not sensitive to
SDS, indicating that the outer membrane is intact in this strain, or,
intriguingly, to chloramphenicol, a known substrate of the MdfA
efflux pump (Fig. 1D; Table 1). Remarkably, BC202 is sensitive to
concentrations of EthBr that are roughly 10-fold lower than what
is needed to kill an mdfA mutant (Fig. 1A; Table 1). Expression of
either yqjA or yghB individually was capable of restoring resistance
to BC202, indicating that these proteins have redundant functions
(see Fig. S1 in the supplemental material). These results indicate
that YqjA and YghB either are directly involved in drug efflux or
are required for proper function of other membrane transporters.
Deletion of known efflux pumps causes an increase in BC202
sensitivity. Introducing deletions of known transporters into
BC202 consistently resulted in a marked increase in drug sensitiv-
ity on both solid and liquid media (Fig. 1A to C; Table 1). MdfA
and EmrE have been proposed to be the major contributors to
EthBr resistance of E. coli (30). The presence of either the mdfA
or emrE mutation in the BC202 background strain results in
additional sensitivity, suggesting independent resistance mecha-
nisms by these protein families. We see the same pattern with
other biocides and the mutants of the corresponding export pro-
teins involved in their efflux, including EthBr, acriflavine, and
methyl viologen (Fig. 1A to C; Table 1). Strikingly, the presence of
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the acrB deletion in BC202 results in a nearly synergistic increase
in sensitivity to a number of compounds, including SDS, many-
fold higher than what is observed in either background individu-
ally (Table 1). These results suggest that the effect on drug sensi-
tivity of these DedA family deletions is independent of other
known drug transporters.
Membrane-embedded acidic amino acids are essential for
function of DedA family members. In many multidrug resistance
(MDR) transporters, including MdfA, TetL, and EmrE, it has been
demonstrated that membrane-embedded acidic residues such as
glutamic acid (E) and aspartic acid (D) play a role in PMF-depen-
dent drug transport (Table 2) (31–35). E26 and D34 both play
roles in proton translocation in exchange of substrate by MdfA
(35). Many DedA proteins contain a predicted membrane-em-
bedded or membrane-proximal glutamic acid and/or aspartic acid
in the first transmembrane-spanning (TMS) region (E39 and D51
in YqjA and YghB [Table 2]). We performed site-directed mu-
tagenesis on these residues and found the YqjA point mutants
(YqjA-E39A and YqjA-D51A) no longer restored growth at 42°C
(Fig. 2A), cell division (Fig. 2B), or drug resistance (Fig. 2C) when
FIG 1 Sensitivity of BC202, multidrug resistance mutants, and combination mutants to selected biocides. (A to C) BC202 (yghB yqjA) is sensitive to ethidium
bromide (EthBr) (A), methyl viologen (MV) (B), and acriflavine (Acr) (C), while the corresponding multidrug resistance mutants display sensitivity approxi-
mately equal to or less than that of BC202. MdfA promotes EthBr resistance, EmrE promotes MV resistance, and AcrB is required for acriflavine resistance (19).
Combination mutants (with multidrug resistance gene deletions in the BC202 genetic background) display additive or synergistic sensitivity (see also Table 1).
(D) BC202 is not appreciably sensitive to SDS, chloramphenicol (CAM), ciprofloxacin (Cipro), norfloxacin (Norflox), or erythromycin (Erythro) on solid LB
plates. Dilutions of log-phase cells of the indicated genotype were spotted onto LB plates containing the indicated concentrations of biocide. All strains grew
equally well on LB plates with no added biocide.













SDS (%) 	1 	1 	1 	1 	1 	1 0.5 0.06
CAM (g/ml) 6.0 6.0 3.0 3.0 6.0 6.0 0.4 0.4
BC (g/ml) 25 6.3 6.3 6.3 12.5 3.1 0.8 0.2
NA (g/ml) 6.0 3.0 6.0 3.0 6.0 1.6 3.0 0.4
CTAB (g/ml) 12.5 6.3 6.3 3.1 6.3 1.6 1.6 1.6
MV (g/ml) 100 25 100 25 25 12.5 100 25
Acr (g/ml) 100 12.5 50 6.3 25 6.3 6.3 0.8
EthBr (g/ml) 400 25 200 12.5 200 12.5 3.1 0.8
Erythro (g/ml)c 100 50 100 50 100 50 6.3 3.1
Cipro (ng/ml)c 5.0 2.5 5.0 2.5 5.0 2.5 1.25 0.3
Norflox (ng/ml)c 40 20 40 20 40 20 20 5.0
Ox (g/ml) 400 200 ND ND ND ND 25 3.1
Clox (g/ml) 400 200 ND ND ND ND 25 3.1
Pip (g/ml) 2 0.5 ND ND ND ND 0.25 0.03
a W3110 (parent), BC202, and mutants with efflux pump mutations in either the W3110 (mdfA, emrE, and acrB) or BC202 (BC202M, BC202E, and BC202A) background
strain were grown in liquid culture in the presence of a series of dilutions of the indicated compounds. Abbreviations: SDS, sodium dodecyl sulfate; CAM, chloramphenicol; BC,
benzalkonium chloride; NA, nalidixic acid; CTAB, cetyl trimethyl ammonium bromide; MV, methyl viologen; Acr, acriflavine hydrochloride; EthBr, ethidium bromide; Erythro,
erythromycin; Cipro, ciprofloxacin; Norflox, norfloxacin; Ox, oxacillin; Clox, cloxacillin; Pip, piperacillin; ND, not determined.
b In strain BC202, increased sensitivity to the indicated compounds is shown in italic. In strains BC202M, BC202E, and BC202A, additive or synergistic effects are shown in bold.
c BC202 was not sensitive to erythromycin, ciprofloxacin, and norfloxacin on plates (Fig. 1 and data not shown) but was slightly sensitive in liquid culture.
DedA Family Proteins Required for Drug Efflux



























































expressed in BC202. Mutant protein expression levels were equiv-
alent to wild-type levels in purified membranes (Fig. 2D), demon-
strating that the mutant proteins were correctly folded. Wild-type
yqjA completely restored growth and cell division (Fig. 2A and B),
in agreement with previous reports (8, 11), as well as drug resis-
tance to BC202 (Fig. 2C). To further support these data, we cre-
ated isosteric substitutions at positions E39 and D51 in YqjA, con-
verting these residues to glutamine and asparagine, respectively.
YqjA-E39Q and YqjA-D51N were unable to restore drug resis-
tance (Fig. 3A), growth at 42°C (see Fig. S2A in the supplemental
material), or normal cell division (see Fig. S2B in the supplemental
material) to BC202. Again, levels of mutant protein found in the
membrane were similar to those of the wild-type YqjA (Fig. 3B).
This suggests that the charge carried by amino acids E39 and D51
is essential for the function of YqjA. Similar observations were
made with YghB and its corresponding point mutants YghB-E39A
and YghB-D51A (see Fig. S3 in the supplemental material). The
presence of membrane-embedded acidic amino acids that are es-
sential for activity suggests that YqjA and YghB may be proton-
dependent transporters.
We were interested in determining whether these properties
applied to DedA family members found in other bacterial species.
BB0250 is the sole DedA family protein of the Lyme disease patho-
gen Borrelia burgdorferi and is essential for viability (36). Deple-
tion of BB0250 in B. burgdorferi results in cell death preceded by
defects in cell division. In other words, the Borrelia mutant phe-
notypes resemble those of BC202, with the exception being that
bb0250 is essential at all temperatures. In addition, cloned bb0250
can fully complement the growth and cell division phenotypes of
E. coli BC202 even though BB0250 displays only 19% amino
TABLE 2 Membrane-embedded acidic amino acids in TM1 of DedA family proteins and selected drug transport proteinsa
Protein name TM1 amino acid sequenceb Accession no. Family
YqjA FVLFVILFLENGLLPAAFLPGDS NP417566 DedA
YghB IVSVVYFVMFATLFLENGLLPAS(FLPGD)c NP417482 DedA
BB0250 VFFSLLILAGLNVPISEDAIVLMd NP212384 DedA
MdfA RLGRQALLFPLCLVLYEFSTYIG(ND)e P0AEZ0 12-TMS family of the MFS
TetL LIWLCILSFFSVLNEMVLNVSLP AAB09024 14-TMS family of the MFS
EmrE NPYIYLGGAILAEVIGTTLMKFS P23895 4-TMS family of the SMR family
a Database sequences were analyzed for predicted membrane domains using SOSUI (45). This table is for illustration purposes only and is not a complete list of transport proteins.
Abbreviations: TM1, transmembrane region 1; MFS, major facilitator superfamily; SMR, small multidrug resistance.
b Conserved acidic amino acids are shown in bold.
c YghB D51 is predicted to lie just outside TM1 but is also required for function (see Fig. S3 in the supplemental material).
d BB0250 is an essential DedA family protein of Borrelia burgdorferi (36). E39 and D40 are each required for BB0250 to complement growth and cell division defects of BC202 (see
Fig. S3 in the supplemental material).
e E26 and D34 both play roles in transport by MdfA (35).
FIG 2 Mutation of YqjA E39 or D51 abolishes the ability to restore growth, cell division, or drug resistance to BC202. (A) BC202 transformed with pBAD,
pBAD-yqjA, pBAD-yqjA(E39A), or pBAD-yqjA(D51A) was grown at 30°C (left) or 42°C (center and right). Wild-type YqjA, but not point mutants, restores
growth to BC202 at 42°C. BC202/pBAD-yqjA(D51A) also grew at 30°C (not shown). (B) Micrographs of BC202 transformed with pBAD, pBAD-yqjA, pBAD-
yqjA(E39A), or pBAD-yqjA(D51A) and grown at 30°C. Wild-type YqjA, but not point mutants, restores normal cell division to BC202. Bar, 10 m. (C) Sensitivity
of BC202 transformed with control vector, cloned yqjA, yqjA(E39A), or yqjA(D51A) to EthBr (75 g/ml), acriflavine (25 g/ml), nalidixic acid (0.5 g/ml), and
methyl viologen (25 g/ml). All strains grew on LB plates without biocides at 30°C. Wild-type YqjA, but not point mutants, restores drug resistance to BC202 at
30°C. (D) Expression of yqjA, yqjA(E39A), and yqjA(D51A) in membrane fractions as determined by Western blotting with antihexahistidine antibody. All
growth was carried out in LB-Amp supplemented with 0.002% (A and C) or 0.1% (B and D) arabinose.
Kumar and Doerrler



























































acid identity to E. coli YqjA. BB0250 also possesses acidic amino
acids within its first predicted transmembrane domain (Table 2).
We performed site-directed mutagenesis on residues E39 and D40
in TM1 of BB0250, replacing each with alanine, and showed that
each point mutant is unable to restore cell division, temperature
sensitivity, and drug resistance to BC202 (Fig. 4A to C) while also
being expressed in the membrane at wild-type levels (Fig. 4D).
These data collectively suggest that members of the larger DedA
family are proton-dependent membrane transporters necessary
for resistance to a number of structurally diverse compounds in E.
coli and likely other species of bacteria.
Artificially increasing PMF restores drug resistance to
BC202. One potential explanation for these results is that YqjA/
YghB are themselves drug efflux pumps. Alternatively, these DedA
family proteins may indirectly affect the ability of other efflux
pumps to function by compromising the proton motive force
(PMF). A role for YqjA/YghB in PMF maintenance is supported
by our own published data showing correction of BC202 growth
and cell division by growth at acidic pH or by overexpression of
the Na-K/H antiporter MdfA (10). PMF is also required for
proper functioning of the twin-arginine transport pathway (37),
which functions inefficiently in BC202, leading to the observed
cell division defect (9). To directly test this question, we expressed
mdfA from a plasmid in BC202 and tested its sensitivity to the
collection of biocides to which it is sensitive. If mdfA overexpres-
sion corrects sensitivity to all drugs, this would support a role for
YqjA/YghB in PMF maintenance, which is indirectly affecting the
drug export mechanism. We found that expression of mdfA cor-
rects sensitivity of BC202 to all drugs, including those that are not
FIG 3 Isosteric substitutions of YqjA E39 or D51 abolish the ability to restore
drug resistance to BC202. (A) Sensitivity of BC202 transformed with control
vector pBAD, cloned yqjA, yqjA(E39Q), or yqjA(D51N) to benzalkonium
chloride (20 g/ml), acriflavine (25 g/ml), CTAB (100 g/ml), EthBr (75
g/ml), and methyl viologen (30 g/ml). All strains grew on LB plates without
biocides at 30°C. Wild-type YqjA, but not point mutants, restores drug resis-
tance to BC202 at 30°C. (B) Expression of yqjA, yqjA(E39Q), and yqjA(D51N)
in membrane fractions as determined by Western blotting with antihexahisti-
dine antibody. All growth was carried out in LB-Amp supplemented with
0.002% (A) or 0.1% (B) arabinose.
FIG 4 Inability of Borrelia burgdorferi BB0250 E39A and D40A point mutants to restore growth, cell division, or drug resistance to BC202. (A) BC202 was
transformed with empty vector pBB0, pBB0250-GFP, pBB0250(E39A)-GFP, or pBB0250(D40A)-GFP and grown at 30 or 42°C. BC202/pBB0250(D40A)-GFP
also grew at 30°C (not shown). Expression of wild-type but not mutant BB0250 restored growth to BC202 at 42°C. (B) BC202 was transformed with empty vector,
pBB0250-GFP, pBB0250(E39A)-GFP, or pBB0250(D40A)-GFP and grown at 30°C in liquid medium. Cells were visualized using a Leica DM-RXA2 deconvo-
lution microscope. Bar, 10 m. Expression of wild-type but not mutant BB0250 restored normal cell division to BC202. The ability of wild-type BB0250, included
as a positive control, to restore both growth and cell division to BC202 is in agreement with previously published results (36). (C) Sensitivity of BC202
transformed with control vector, pBB0250-GFP, pBB0250(E39A)-GFP, or pBB0250(D40A) to EthBr (50 g/ml), acriflavine (25 g/ml), cetyltrimethyl ammo-
nium bromide (CTAB) (100 g/ml), and methyl viologen (30 g/ml). All strains grew on LB plates without biocides at 30°C. Wild-type BB0250, but not point
mutants, restores drug resistance to BC202 at 30°C. (D) Expression of bb0250, bb0250(E39A), and bb0250(D40A) in membrane fractions as determined by
Western blotting with anti-GFP antibody. All growth was carried out in LB-Amp supplemented with 0.5 mM IPTG.
DedA Family Proteins Required for Drug Efflux



























































transported directly by MdfA (19, 28, 35) (i.e., acriflavine, methyl
viologen, and nalidixic acid) (Fig. 5A). Growth at pH 6.0 (increas-
ing the pH component of the PMF) also restores drug resistance
to BC202 on both solid and liquid media (Fig. 5B and Table 3),
indicating that the sensitivity is likely due to loss of PMF. Growth
in the presence of 400 mM NaCl or 10 mM Mg2, both conditions
that restore growth and cell division to BC202 (8, 10), also restores
BC202 drug resistance to most compounds tested (see Fig. S4 in
the supplemental material). Each of these conditions that restore
resistance (mdfA expression or growth at pH 6.0 or in the presence
of 400 mM NaCl or 10 mM Mg2) likely assists in restoring pH
homeostasis to BC202 (see Discussion) (10).
DISCUSSION
Members of the DedA family of membrane proteins are found in
the vast majority of completed bacterial genomes (4), and there
are virtually thousands of DedA members in the protein data-
bases. While it has been reported that members of this family are
evolutionarily related to the LeuT superfamily of transporters (6),
they have never been defined as true membrane transporters. De-
letion of functionally redundant genes yqjA and yghB in strain
BC202 causes a number of pleiotropic effects in E. coli. BC202 is
unable to grow at elevated temperatures or to complete cell divi-
sion (8, 9), and it activates numerous envelope stress responses
(10). In this work, we show that BC202 is highly sensitive to several
cationic biocides that are known substrates of PMF-dependent
efflux pumps. It appears that loss of YqjA and YghB may indirectly
cause massive drug sensitivity due to impairment of the PMF in
BC202. This is likely the reason that Salmonella yqjA mutants are
sensitive to magainin (38), a cationic antimicrobial peptide that
likely disrupts the membrane PMF (39). In addition, PMF-dis-
rupting lipopeptides have recently been reported to sensitize E.
coli to a number of antibiotics (40).
Overexpression of DedA family genes in BC202 does not by
FIG 5 mdfA overexpression or growth at pH 6.0 restores drug resistance to BC202. (A) BC202 harboring vector alone or pBAD-MdfA was spotted on plates
containing LB (Amp, 0.1% arabinose) alone or this medium supplemented with 20 g/ml benzalkonium chloride (BC) (exported by MdfA), 1 g/ml nalidixic
acid (NA) (exported by AcrAB), 30 g/ml methyl viologen (MV) (exported by EmrE), 25 g/ml acriflavine (Acr) (exported by AcrAB), 100 g/ml cetyl trimethyl
ammonium bromide (CTAB) (mainly exported by AcrAB), or 50 g/ml ethidium bromide (EthBr) (exported by MdfA, EmrE, and others). (B) BC202 and the
parent W3110 was spotted on LB plates buffered to pH 6.0 or 7.0 and containing no additive, 10 g/ml BC, 1 g/ml NA, 25 g/ml MV, 25 g/ml Acr, 50 g/ml
CTAB, or 100 g/ml EthBr. LB medium was buffered at pH 6.0 or 7.0 as described previously (10). Nalidixic acid was toxic to both strains at pH 6.0 for unknown
reasons.
TABLE 3 MICs for W3110 and BC202 in LB medium adjusted to pH
6.0a
Compound








a The pH of LB medium was adjusted to 6 as described in Materials and Methods.
Abbreviations are as for Table 1.
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itself increase resistance to any of the biocides tested here beyond
the level of resistance seen in parent strain W3110 (Fig. 2 and 4; see
Fig. S3 in the supplemental material). However, the essentiality of
membrane-embedded amino acids strongly suggests that DedA
proteins themselves are proton-dependent transporters, as similar
acidic amino acids are found in many other classes of such trans-
porters. In the case of MdfA, is has been shown that acidic amino
acids E26 and D34 play roles in proton translocation during sub-
strate transport (35). It is possible that such amino acids serve a
similar function for DedA family proteins. Whether this family
also functions as antiporters and the nature of the transported
substrate(s) is currently unknown.
Growth at 42°C, normal cell division, and wild-type drug re-
sistance can be restored to BC202 by overexpression of mdfA (Fig.
5A) or growth at pH 6.0 (Fig. 5B) or in the presence of 400 mM
NaCl or 10 mM Mg2 (see Fig. S4 in the supplemental material)
(400 mM NaCl did not restore resistance to 50 g/ml CTAB, for
reasons that are unclear [see Fig. S4 in the supplemental mate-
rial]). It is likely that each of these conditions helps to restore an
altered cytoplasmic pH. For example, MdfA is an antiporter that
can provide proton influx in exchange for Na or K (16). In a
similar manner, medium buffered to pH 6.0 results in an in-
creased pH component of the PMF. An increase in extracellular
Mg2 can enhance membrane integrity and can also inhibit the
activity of the Fo/F1 proton-transporting ATPase (41), which is
also upregulated in response to alkaline growth conditions (12).
Finally, high levels of monovalent cations such as Na or K can
stimulate a number of proton-dependent antiporters, such as
NhaA and MdfA, which play critical roles in cellular pH homeo-
stasis (16, 42). Interestingly, the ability of 400 mM Na or 10 mM
Mg to restore growth and cell division to BC202 is dependent
upon an intact Cpx envelope stress response pathway, suggesting
that some Cpx-induced gene may be required for this effect (10).
One of the more interesting properties of the DedA family that
sets it apart from many membrane transporter families is its ap-
parent essentiality. This is supported by several lines of evidence.
First, the DedA family is collectively essential in E. coli (11), and
essential DedA genes are found in Borrelia burgdorferi (BB0250)
(36) and Caulobacter crescentus (CCNA_01607) (43). Further-
more, expression of a DedA family gene from Mycobacterium bovis
BCG (BCG2664) confers resistance to and may be the target of the
antituberculosis drug halicyclamine A (44). In this work, we show
that members of the DedA family may be membrane transporters
and that they are required for the normal function of several fam-
ilies of drug efflux pumps, possibly due to their requirement for
PMF maintenance. DedA family proteins are thus an intriguing
class of membrane proteins and potential targets for antibacterial
drug design.
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